Anebulo Pharmaceuticals, Inc. (ANEB) reported a loss of -$2.14 million for the fourth quarter. Earnings were -$0.05 per share, compared to -$1.35 million or -$0.05 per share last year. The company’s GAAP earnings show a loss of -$2.14 million, with EPS of -$0.05, compared to -$1.35 million and -$0.05 last year.

Read more at Nasdaq: Anebulo Pharmaceuticals, Inc. Loss At -$2.14 Mln In Q4